Literature DB >> 9375376

Neuronal Cdc2-like kinases: neuron-specific forms of Cdk5.

K Y Lee1, Z QI, Y P Yu, J H Wang.   

Abstract

Neuronal Cdc2-like kinase, Nclk, is a heterodimer of a Cdk5 catalytic subunit and a 25 kDa regulatory subunit derived proteolytically from a neuron- and central nervous system-specific 35 kDa protein. The regulatory subunit is mandatory for kinase activity, hence it is designated the neuronal Cdk5 activator, p25/p35nck5a. Nclk has been suggested to play a regulatory role in neuro-cytoskeleton dynamics and in neuronal differentiation. In addition to the activation by Nck5a, Cdk5 is regulated by other mechanisms including additional activator proteins and inhibition by phosphorylation of specific amino acid residues. While Nclk shares common catalytic and regulatory properties with other members of the cdc2-like kinase family, it also displays unique characteristics that may be important for its neuronal functions.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9375376     DOI: 10.1016/s1357-2725(97)00048-4

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  13 in total

1.  Novel alternatively spliced variant form of human CDK5RAP2.

Authors:  Tom Kim; John S Y Park; Paul Lee; Yan Jin; Song-bin Fu; Jesusa L Rosales; Ki-Young Lee
Journal:  Cell Cycle       Date:  2011-03-15       Impact factor: 4.534

2.  Mammalian Cdk5 is a functional homologue of the budding yeast Pho85 cyclin-dependent protein kinase.

Authors:  D Huang; G Patrick; J Moffat; L H Tsai; B Andrews
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-07       Impact factor: 11.205

3.  In vivo analysis of the domains of yeast Rvs167p suggests Rvs167p function is mediated through multiple protein interactions.

Authors:  K Colwill; D Field; L Moore; J Friesen; B Andrews
Journal:  Genetics       Date:  1999-07       Impact factor: 4.562

4.  Cdk5 mediates vimentin Ser56 phosphorylation during GTP-induced secretion by neutrophils.

Authors:  Ki-Young Lee; Lijuan Liu; Yan Jin; Song-Bin Fu; Jesusa L Rosales
Journal:  J Cell Physiol       Date:  2012-02       Impact factor: 6.384

Review 5.  Interplay between the p53 tumor suppressor protein family and Cdk5: novel therapeutic approaches for the treatment of neurodegenerative diseases using selective Cdk inhibitors.

Authors:  Gerald Schmid; Joanna B Strosznajder; Józefa Wesierska-Gadek
Journal:  Mol Neurobiol       Date:  2006-08       Impact factor: 5.590

6.  Induction of cyclin-dependent kinase 5 in the hippocampus by chronic electroconvulsive seizures: role of [Delta]FosB.

Authors:  J Chen; Y Zhang; M B Kelz; C Steffen; E S Ang; L Zeng; E J Nestler
Journal:  J Neurosci       Date:  2000-12-15       Impact factor: 6.167

7.  Differential growth factor regulation of aspartyl-(asparaginyl)-beta-hydroxylase family genes in SH-Sy5y human neuroblastoma cells.

Authors:  Stephanie A Lahousse; Jade J Carter; Xaolai J Xu; Jack R Wands; Suzanne M de la Monte
Journal:  BMC Cell Biol       Date:  2006-12-07       Impact factor: 4.241

Review 8.  Targeting cyclin-dependent kinases in human cancers: from small molecules to Peptide inhibitors.

Authors:  Marion Peyressatre; Camille Prével; Morgan Pellerano; May C Morris
Journal:  Cancers (Basel)       Date:  2015-01-23       Impact factor: 6.639

9.  Identification of a novel, membrane-associated neuronal kinase, cyclin-dependent kinase 5/p35-regulated kinase.

Authors:  Sashi Kesavapany; Kwok-Fai Lau; Steven Ackerley; Steven J Banner; Stephen J A Shemilt; Jonathan D Cooper; P Nigel Leigh; Christopher E Shaw; Declan M McLoughlin; Christopher C J Miller
Journal:  J Neurosci       Date:  2003-06-15       Impact factor: 6.167

Review 10.  Physiological and pathological phosphorylation of tau by Cdk5.

Authors:  Taeko Kimura; Koichi Ishiguro; Shin-Ichi Hisanaga
Journal:  Front Mol Neurosci       Date:  2014-07-15       Impact factor: 5.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.